Tuesday's UK broker ratings

2 July

Updated every day, our UK broker ratings identify which FTSE- and AIM-listed companies are affected by a ratings change.

Listed below are details of selected companies that have undergone a ratings change today. Alternatively, download the PDF to see a full list of today's UK Broker Ratings.

UK broker ratings (9KB)


Pdfs require Adobe Reader, which is available free from  Adobe.

Upgrade

Company

Rating

Target price

Potential upside/Downside

Contributing broker

Burberry Group Overweight 1750 23.9% HSBC
John Menzies Add 834 20.8% Numis Securities Ltd
Rexam Buy 550 10.8% Jefferies

Maintain

Company

Rating

Target price

Potential upside/Downside

Contributing broker

Petrofac Ltd Buy 1740 44.3% Nomura
Michael Page International Outperform 520 34.3% RBC Capital Markets
Marks & Spencer Group Buy 581 33.1% Societe Generale

Downgrade

Company

Rating

Target price

Potential upside/Downside

Contributing broker

Royal Bank of Scotland Group Neutral 300 7.4% HSBC

Source: Bloomberg (2 July 2013)

This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.